The American Journal of Medicine is offering a new continuing medical education course entitled: Advances in the Management of Patients with Hyponatremia.
Program Overview
This continuing medical education activity represents a comprehensive summary of the diagnosis and treatment of all types of hyponatremia. The expert faculty present specific treatment recommendations according to the extracellular fluid volume status and the specific etiology of the hyponatremia. Rationale for effective treatment strategies are based on the in depth analysis of clinical presentation and the progress of patient data. The application of updated expert panel recommendations for goals and limits of the correction of hyponatremia are presented through case based discussions. The goal is to optimize outcomes and prevent osmotic demyelination syndrome (ODS) in patients with hyponatremia. Recently, data has become available for a new class of vasopressin receptor antagonists, also called vaptans. The expert faculty highlight recommendations for when and how to use this newer class of therapeutics.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Recognize the signs and symptoms important to the early diagnosis of patients with hyponatremia.
- Describe the pathophysiology and therapeutic targets of SIADH, including arginine vasopressin receptors.
- Review the efficacy and safety data of pharmacotherapies for the treatment of patients with hyponatremia and SIADH.
- Identify the role of vasopressin receptor antagonists in the management of patients with hyponatremia.
For the faculty list, registration, and log in, go here.
